Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment

Journal of Hypertension

Volumn 13, Issue 10, 1995, Pages 1091-1095

  Muiesan, Lorenza M ^a   Salvetti, Massimo ^a   Rizzoni, Damiano ^a   Castellano, Maurizio ^a   Donato, Francesco ^a   Agabiti Rosei, Enrico ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Left ventricular hypertrophy; Prognosis; Regression

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; STATISTICAL ANALYSIS; SURVIVAL;

EID: 0028807479     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199510000-00003     Document Type: Article

References (13)

1. Kannel WB, Cordon T, Offut T: Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence and mortality in the Framingham study. Ann Int Med 1969, 71:89-105.
2. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Fleart Study. N Engl J Med 1990, 322:1561-1566.
3. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, et al.: Value of echocardiographic left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Int Med 1986, 105:173-178.
4. Cruickshank JM, Lewis J, Moore V, Dodd A: Reversibility of left ventricular hypertrophy by differing types of antihypertensive therapy. J Hum Hypertens 1992, 6:85-90.
5. Agabiti-Rosei E, Muiesan ML: Reversal of cardiovascular structural changes during long-term antihypertensive therapy. J Hum Hypertens 1991, 5 (suppl 1):41-47.
6. Sahn DJ, DeMaria A, Kisslo J, Weyman A: The Committee on M-mode standardization of the American Society of echocardiography: recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1978, 58:1072-1083.
7. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al.: Echocardiographic assessment on left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986, 57:450-458.
8. Devereux RB, Lutas EM, Casale PN, Kligfield P, Eisenberg RR, Hammond IW, et al.: Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol 1984, 4:1222-1230.
9. Levy D, Salomon M, D’Agostino R, Belanger A, Kannel WB: Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 1994, 90:1786-1793.
10. Koren MJ, Savage DD, Casale PN, Laragh JH, Devereux RB: Changes in left ventricular mass predict risk in essential hypertension [abstract]. Circulation 1990, 82 (suppl III): III29.
11. Yurenev AP, Dyakonova HG, Novikov ID, Vitols A, Pahl L, Haynemann G: Management of essential hypertension in patients with different degrees of left ventricular hypertrophy. Am J Hypertens 1992, 5 (part 2): 182S-189S.
12. Roman MJ, Pickering TG, Schwartz JE, Pini R, Devereux RB: Association of carotid atherosclerosis and left ventricular hypertrophy. J Am Coll Cardiol 1995, 25:83-90.
13. Zanchetti A, Sleight P, Birkenhager WH: Evaluation of organ damage in hypertension [consensus document]. High Blood Press 1993, 2 (suppl 1):93-105.